imatinib mesylate has been researched along with Cancer of Eye in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, A; Aslam, HM; Bashir, S; Hashmi, AS; Malik, B; Mumtaz, S; Tariq, M | 1 |
| Bernardeschi, P; De Giorgi, U; Dentico, P; Fiorentini, G; Lanzanova, G; Rossi, S | 1 |
| Duch-Samper, A; Hurtado-Sarrió, M; Martínez-Dominguez, JA; Menezo-Rozalén, JL; Senent-Peris, ML; Taboada-Esteve, J | 1 |
| Bernardeschi, P; Biancalani, M; De Giorgi, U; Dentico, P; Fiorentini, G; Lanzanova, G; Palomba, A; Rossi, S | 1 |
1 trial(s) available for imatinib mesylate and Cancer of Eye
| Article | Year |
|---|---|
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.
Topics: Adult; Benzamides; Biomarkers, Tumor; Eye Neoplasms; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Melanoma; Middle Aged; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines | 2003 |
3 other study(ies) available for imatinib mesylate and Cancer of Eye
| Article | Year |
|---|---|
Orbital dermatofibrosarcoma protuberans with intracranial extension preceded by recurrent leiomyoma of the orbit: a case report.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Combined Modality Therapy; Dermatofibrosarcoma; Eye Neoplasms; Humans; Imatinib Mesylate; Leiomyoma; Male; Middle Aged; Oncogene Proteins, Fusion; Orbit; Skin Neoplasms | 2015 |
Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117).
Topics: Adult; Aged; Benzamides; Eye Neoplasms; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Liposarcoma; Male; Melanoma; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines | 2003 |
Anterior chamber infiltration in a patient with Ph+ acute lymphoblastic leukemia in remission with imatinib.
Topics: Anterior Chamber; Antineoplastic Agents; Aqueous Humor; Benzamides; Eye Neoplasms; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Middle Aged; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Uveitis, Anterior | 2005 |